References
Corman SL, Mohammad RA (2010) Eltrombopag: a novel oral thrombopoietin receptor agonist. Ann Pharmacother 44(6):1072–1079
Kellum A et al (2010) A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors. Curr Med Res Opin 26(10):2339–2346
Jenkins JM et al (2007) Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 109(11):4739–4741
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duic, J.P., Grewal, J., McConie, K. et al. Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient. J Neurooncol 106, 427–429 (2012). https://doi.org/10.1007/s11060-011-0675-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-011-0675-5